Citation Impact
Citing Papers
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
2008
Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors
2010
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Molecular imaging of hypoxia with radiolabelled agents
2009
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
2011 StandoutNobel
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
2013
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study
2015
The impact of O2 availability on human cancer
2008
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Nasopharyngeal carcinoma
2005 Standout
Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)
2008
Molecular imaging in drug development
2008 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
2007
Targeting hypoxia in cancer therapy
2011 Standout
A view on drug resistance in cancer
2019 StandoutNature
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma
2003
Hypoxia, HIF1 and glucose metabolism in the solid tumour
2008
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: A prospective international multi-center study
2006
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Targeting hypoxia cell signaling for cancer therapy
2007
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Drug penetration in solid tumours
2006 Standout
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
2007
Imaging in the era of molecular oncology
2008 StandoutNature
Lung Cancer
2008 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system
2015
Nasopharyngeal carcinoma
2019 Standout
Primary CNS Lymphoma: Treatment with Combined Chemotherapy and Radiotherapy
1999
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
2011
Clinical Significance of Postradiotherapy [18F]-Fluorodeoxyglucose Positron Emission Tomography Imaging in Management of Head-and-Neck Cancer—A Long-Term Outcome Report
2008
Hypoxia Induced by Upconversion‐Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors
2015
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
2012
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Assessing responses to cancer therapy using molecular imaging
2006
Role of Radiation Therapy in Cutaneous Melanoma
2012
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
2003
Use of Three-Dimensional Tissue Cultures to Model Extravascular Transport and Predict In Vivo Activity of Hypoxia-Targeted Anticancer Drugs
2006
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
Oxygen Dependence and Extravascular Transport of Hypoxia-Activated Prodrugs: Comparison of the Dinitrobenzamide Mustard PR-104A and Tirapazamine
2007
Nasopharyngeal carcinoma
2015 Standout
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
2009
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Malignant Gliomas in Adults
2008 Standout
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer
2015 StandoutNobel
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
2010
The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
2007
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
2006
Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards
2007
The battle against nasopharyngeal cancer
2012
Mechanisms of Disease: cancer stem cells—targeting the evil twin
2008
Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levels
2006
Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era
2014
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site
2016
Primary brain tumours in adults
2012 Standout
Targeting tumors with hypoxia-activated cytotoxins
2007
Hsp70 and CHIP Selectively Mediate Ubiquitination and Degradation of Hypoxia-inducible Factor (HIF)-1α but Not HIF-2α
2009 StandoutNobel
Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription
2012
CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma
2001
The PI3K Pathway in Human Disease
2017 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Expression and Prognostic Significance of a Panel of Tissue Hypoxia Markers in Head-and-Neck Squamous Cell Carcinomas
2007
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Brain Tumors
2001 Standout
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
2010
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
2017
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Head and Neck Cancer
2020 Standout
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
2005
Hypoxia-Selective 3-Alkyl 1,2,4-Benzotriazine 1,4-Dioxides: The Influence of Hydrogen Bond Donors on Extravascular Transport and Antitumor Activity
2007
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
2013
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma
2001
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
2003
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Adjuvant Therapy in Patients With Resected Poor-Risk Head and Neck Cancer
2006
Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Spin Trapping of Radicals Other Than the•OH Radical upon Reduction of the Anticancer Agent Tirapazamine by Cytochrome P450Reductase
2009
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma
2000
Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA
2004
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Multimodality imaging of hypoxia in preclinical settings.
2010
Works of June Corry being referenced
Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
2011
Primary central nervous system lymphoma: age and performance status are more important than treatment modality
1998
A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma
2013
Hypoxia in Head and Neck Cancer: Studies With Hypoxic Positron Emission Tomography Imaging and Hypoxic Cytotoxins
2007
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer
2004
Nodal radiation therapy for metastatic melanoma
1999
Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma
2012
Usefulness of fluorine‐18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck
2004
Radiation with concurrent late chemotherapy intensification (‘chemoboost’) for locally advanced head and neck cancer
2000
Safety and cost analysis of an 18FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation
2015
‘Boomerang’ technique: An improved method for conformal treatment of locally advanced nasopharyngeal cancer
2004
Optimising the therapeutic ratio in head and neck cancer
2010
The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancer
2005
Relapse patterns in WHO 2/3 nasopharyngeal cancer: Is there a difference between ethnic Asian vs. non-Asian patients?
2005
Prolonged Remission in a Patient With Nasopharyngeal Carcinoma With a Solitary Bone Metastasis
2010
Strategies to overcome accelerated repopulation and hypoxia—what have we learned from clinical trials?
2004
Rising prevalence of human papillomavirus–related oropharyngeal cancer in Australia over the last 2 decades
2014
Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome
2014
Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
2004
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
2006
Excellent Disease Control and Survival in Patients With Advanced Nasopharyngeal Cancer Treated With Chemoradiation
2002